Home/Filings/4/0001415889-24-019534
4//SEC Filing

Farnum Rhonda 4

Accession 0001415889-24-019534

CIK 0001583107other

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 6:15 PM ET

Size

4.8 KB

Accession

0001415889-24-019534

Insider Transaction Report

Form 4
Period: 2024-07-10
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
  • Sale

    Ordinary Shares

    2024-07-10$9.00/sh4,000$36,000335,965 total
Footnotes (1)
  • [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/14/2024.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001898490

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 6:15 PM ET
Size
4.8 KB